A detailed history of Wimmer Associates 1, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wimmer Associates 1, LLC holds 9,135 shares of AMGN stock, worth $2.65 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
9,135
Previous 9,160 0.27%
Holding current value
$2.65 Million
Previous $2.86 Million 2.83%
% of portfolio
1.46%
Previous 1.47%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $7,734 - $8,434
-25 Reduced 0.27%
9,135 $2.94 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $4,033 - $4,868
15 Added 0.16%
9,160 $2.6 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $2,557 - $2,884
-10 Reduced 0.11%
9,145 $2.63 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $60,784 - $75,465
278 Added 3.13%
9,155 $2.46 Million
Q1 2023

May 16, 2023

SELL
$225.79 - $275.2 $76,994 - $93,843
-341 Reduced 3.7%
8,877 $2.15 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $28,399 - $36,085
124 Added 1.36%
9,218 $2.42 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $23,568 - $26,580
105 Added 1.17%
9,094 $2.46 Million
Q2 2022

Aug 12, 2022

BUY
$230.71 - $256.74 $37,375 - $41,591
162 Added 1.84%
8,989 $2.19 Million
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $19,515 - $21,588
-89 Reduced 1.0%
8,827 $2.14 Million
Q4 2021

Feb 16, 2022

BUY
$198.88 - $227.6 $11,535 - $13,200
58 Added 0.65%
8,916 $2.01 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $40,119 - $47,004
-189 Reduced 2.09%
8,858 $1.88 Million
Q2 2021

Aug 12, 2021

BUY
$233.58 - $259.14 $19,854 - $22,026
85 Added 0.95%
9,047 $2.21 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $30,179 - $35,169
136 Added 1.54%
8,962 $2.23 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $10,819 - $12,883
-50 Reduced 0.56%
8,826 $2.03 Million
Q3 2020

Dec 03, 2020

BUY
$234.65 - $260.95 $80,954 - $90,027
345 Added 4.04%
8,876 $2.26 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $75,761 - $92,969
-383 Reduced 4.3%
8,531 $2.03 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $110,072 - $145,986
604 Added 7.27%
8,914 $1.81 Million
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $378 - $486
2 Added 0.02%
8,310 $2 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $49,795 - $59,665
286 Added 3.57%
8,308 $1.61 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $16,836 - $19,736
101 Added 1.28%
8,022 $1.48 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $2,532 - $2,854
-14 Reduced 0.18%
7,921 $1.51 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $88,486 - $103,292
496 Added 6.67%
7,935 $1.55 Million
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $185 - $208
1 Added 0.01%
7,439 $1.54 Million
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $46,660 - $52,409
281 Added 3.93%
7,438 $1.37 Million
Q1 2018

May 10, 2018

BUY
$169.43 - $198.0 $57,775 - $67,518
341 Added 5.0%
7,157 $1.22 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $117,309 - $131,070
695 Added 11.35%
6,816 $1.19 Million
Q3 2017

Nov 14, 2017

SELL
$167.29 - $191.0 $25,762 - $29,414
-154 Reduced 2.45%
6,121 $1.14 Million
Q2 2017

Aug 14, 2017

BUY
N/A
6,275
6,275 $1.08 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wimmer Associates 1, LLC Portfolio

Follow Wimmer Associates 1, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wimmer Associates 1, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wimmer Associates 1, LLC with notifications on news.